Leishmania intercepts IFN-γR signaling at multiple levels in macrophages
Tài liệu tham khảo
C.D. Mathers, M. Ezzati, A.D. Lopez, Measuring the burden of neglected tropical diseases: the global burden of disease framework, PLoS Negl. Trop. Dis., 1(2), p. e114, Nov. 2007, doi: 10.1371/journal.pntd.0000114.
Alvar, 2012, Leishmaniasis worldwide and global estimates of its incidence, PLoS ONE, 7, e35671, 10.1371/journal.pone.0035671
Ready, 2013, Biology of Phlebotomine Sand Flies as Vectors of Disease Agents, Annu. Rev. Entomol., 58, 227, 10.1146/annurev-ento-120811-153557
Torres-Guerrero, 2017, Leishmaniasis: A review, F1000Research, 6, 750, 10.12688/f1000research.11120.1
Alexander, 1992, The interaction of Leishmania species with macrophages, Adv. Parasitol., 31, 175, 10.1016/S0065-308X(08)60022-6
de Menezes, 2016, The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis, Parasit. Vectors, 9, 264, 10.1186/s13071-016-1540-3
Laskay, 2003, Neutrophil granulocytes–Trojan horses for Leishmania major and other intracellular microbes?, Trends Microbiol., 11, 210, 10.1016/S0966-842X(03)00075-1
Gupta, 2013, Mechanisms of Immune Evasion in Leishmaniasis, 10.1016/B978-0-12-407679-2.00005-3
Murray, 1983, Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine, J. Clin. Invest., 72, 1506, 10.1172/JCI111107
A. Romano, et al., Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major, PLoS Pathog., 13(6), p. e1006479, Jun. 2017, doi: 10.1371/journal.ppat.1006479.
S. Heyde, et al., CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmission, PLoS Pathog., 14(10), p. e1007374, Oct. 2018, doi: 10.1371/journal.ppat.1007374.
Mosser, 2003, The many faces of macrophage activation, J. Leukoc. Biol., 73, 209, 10.1189/jlb.0602325
Kima, 2013, Interferon gamma in leishmaniasis, Front. Immunol., 4, 156, 10.3389/fimmu.2013.00156
Carrera, 1996, Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice, J. Exp. Med., 183, 515, 10.1084/jem.183.2.515
Marovich, 2000, IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process, J. Immunol., 164, 5858, 10.4049/jimmunol.164.11.5858
Gorak, 1998, Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection, Eur. J. Immunol., 28, 687, 10.1002/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N
von Stebut, 1998, Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity, J. Exp. Med., 188, 1547, 10.1084/jem.188.8.1547
Konecny, 1999, Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro, Eur. J. Immunol., 29, 1803, 10.1002/(SICI)1521-4141(199906)29:06<1803::AID-IMMU1803>3.0.CO;2-F
Qi, 2004, Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis, Infect. Immun., 72, 988, 10.1128/IAI.72.2.988-995.2004
Wanasen, 2007, L-arginine and cationic amino acid transporter 2B regulate growth and survival of Leishmania amazonensis amastigotes in macrophages, Infect. Immun., 75, 2802, 10.1128/IAI.00026-07
X. Ding, et al., Immunomodulatory functions of type I IFN, 16(3) (2013) 387–393, doi: 10.1038/nri3133.Immunomodulatory.
Yip, 1982, Molecular weight of human gamma interferon is similar to that of other human interferons, Science, 215, 411, 10.1126/science.6173921
Davidson, 1965, Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by, 149, 1964
G. Tau, P. Rothman, Biologic functions of the IFN-γ receptors, Allergy: European Journal of Allergy and Clinical Immunology, 54(12). 1999, doi: 10.1034/j.1398-9995.1999.00099.x.
Boehm, 1997, Cellular responses to interferon-γ, Annu. Rev. Immunol., 15, 749, 10.1146/annurev.immunol.15.1.749
M.A. Farrar, R.D. Schreiber, The molecular cell biology of interferon-y and its, 1993.
Novick, 1987, The Human Interferon-y Receptor, J. Biol. Chem., 262, 8483, 10.1016/S0021-9258(18)47439-X
Calderon, 1988, Purification and characterization of the human interferon-y receptor from placenta, 85, 4837
Aguet, 1987, Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon, J. Exp. Med., 165, 988, 10.1084/jem.165.4.988
Cofano, 1990, Affinity purification, peptide analysis, and cDNA sequence of the mouse interferon gamma receptor, J. Biol. Chem., 265, 4064, 10.1016/S0021-9258(19)39703-0
Basu, 1988, Purification and partial characterization of a receptor protein for mouse interferon gamma, Proc. Natl. Acad. Sci. U. S. A., 85, 6282, 10.1073/pnas.85.17.6282
K. Schroder, P.J. Hertzog, T. Ravasi, D.A. Hume, Interferon- : an overview of signals , mechanisms and functions, 75(February), 2004.
Valente, 1992, Distribution of interferon-gamma receptor in human tissues, Eur. J. Immunol., 22, 2403, 10.1002/eji.1830220933
J.K. Whitmire, N. Benning, J.L. Whitton, Cutting Edge: Early IFN-γ Signaling Directly Enhances Primary Antiviral CD4<sup>+</sup> T Cell Responses, J. Immunol., vol. 175, no. 9, pp. 5624 LP – 5628, Nov. 2005, doi: 10.4049/jimmunol.175.9.5624.
J.K. Whitmire, B. Eam, N. Benning, J.L. Whitton, Direct Interferon-γ Signaling Dramatically Enhances CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Memory, J. Immunol., vol. 179, no. 2, pp. 1190 LP – 1197, Jul. 2007, doi: 10.4049/jimmunol.179.2.1190.
Whitmire, 2005, Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection, J. Exp. Med., 201, 1053, 10.1084/jem.20041463
J.S. Haring, G.A. Corbin, J.T. Harty, Dynamic Regulation of IFN-γ Signaling in Antigen-Specific CD8<sup>+</sup> T Cells Responding to Infection, J. Immunol., vol. 174, no. 11, pp. 6791 LP – 6802, Jun. 2005, doi: 10.4049/jimmunol.174.11.6791.
Tau, 2001, Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells, J. Immunol., 167, 5574, 10.4049/jimmunol.167.10.5574
Pernis, 1995, Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells, Science, 269, 245, 10.1126/science.7618088
Bach, 1995, Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets, Science, 270, 1215, 10.1126/science.270.5239.1215
Lexberg, 2010, IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells, Eur. J. Immunol., 40, 3017, 10.1002/eji.201040539
Jackson, 2016, B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6, J. Exp. Med., 213, 733, 10.1084/jem.20151724
Detjen, 2001, Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis, Gut, 49, 251, 10.1136/gut.49.2.251
Celada, 1984, Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity, J. Exp. Med., 160, 55, 10.1084/jem.160.1.55
Ochiai, 1999, Signal Transduction through Interferon-Gamma Receptor on Human Eosinophils, Int. Arch. Allergy Immunol., 118, 443, 10.1159/000024159
Nafziger, 1990, Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors, Eur. J. Immunol., 20, 113, 10.1002/eji.1830200117
Finbloom, 1990, The interferon-gamma receptor on human monocytes, monocyte-like cell lines and polymorphonuclear leucocytes, Biochem. Soc. Trans., 18, 222, 10.1042/bst0180222
Gros, 2011, Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis, J. Allergy Clin. Immunol., 128, 1015, 10.1016/j.jaci.2011.05.043
Hansen, 1990, Characterization of the interaction between recombinant human interferon-gamma and its receptor on human polymorphonuclear leukocytes, J. Leukoc. Biol., 47, 64, 10.1002/jlb.47.1.64
Monte, 1991, Identification and Characterization of a Functional Receptor for Interferon-γ on a Megakaryocytic Cell Line, Blood, 78, 2062, 10.1182/blood.V78.8.2062.2062
Hashioka, 2015, Interferon-γ-induced neurotoxicity of human astrocytes, CNS Neurol. Disord. Drug Targets, 14, 251, 10.2174/1871527314666150217122305
Albieri, 2005, Interferon-gamma alters the phagocytic activity of the mouse trophoblast, Reprod. Biol. Endocrinol., 3, 10.1186/1477-7827-3-34
Kotenko, 1995, Interaction between the components of the interferon gamma receptor complex, J. Biol. Chem., 270, 20915, 10.1074/jbc.270.36.20915
Kaplan, 1996, Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding, J. Biol. Chem., 271, 9, 10.1074/jbc.271.1.9
Sakatsume, 1995, The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors, J. Biol. Chem., 270, 17528, 10.1074/jbc.270.29.17528
Bach, 1996, Ligand-induced assembly and activation of the gamma interferon receptor in intact cells, Mol. Cell. Biol., 16, 3214, 10.1128/MCB.16.6.3214
Schindler, 1992, Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha, Proc. Natl. Acad. Sci. U. S. A., 89, 7836, 10.1073/pnas.89.16.7836
Kovarik, 2001, Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression, EMBO J., 20, 91, 10.1093/emboj/20.1.91
Shuai, 1993, A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma, Science, 261, 1744, 10.1126/science.7690989
Wen, 1995, Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation, Cell, 82, 241, 10.1016/0092-8674(95)90311-9
Uddin, 2002, Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727, J. Biol. Chem., 277, 14408, 10.1074/jbc.M109671200
Shuai, 1994, Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions, Cell, 76, 821, 10.1016/0092-8674(94)90357-3
Meyer, 2004, A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of stat transcription factors, J. Biol. Chem., 279, 18998, 10.1074/jbc.M400766200
Wang, 1994, CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major, J. Exp. Med., 179, 1367, 10.1084/jem.179.4.1367
Pinheiro, 2007, Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice, Mem. Inst. Oswaldo Cruz, 102, 79, 10.1590/S0074-02762007000100013
Carneiro, 2015, IFN-γ-Dependent Recruitment of CD4 + T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection, J. Interferon Cytokine Res., 35, 935, 10.1089/jir.2015.0043
Swihart, 1995, Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response, J. Exp. Med., 181, 961, 10.1084/jem.181.3.961
Kopf, 1996, IL-4-deficient Balb/c mice resist infection with Leishmania major, J. Exp. Med., 184, 1127, 10.1084/jem.184.3.1127
G.F. Späth, P. Schlesinger, R. Schreiber, S.M. Beverley, A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major., PLoS Pathog., 5(4), p. e1000381, Apr. 2009, doi: 10.1371/journal.ppat.1000381.
Rosas, 2003, Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway, Eur. J. Immunol., 33, 1799, 10.1002/eji.200323163
Rosas, 2006, Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani, J. Immunol., 177, 22, 10.4049/jimmunol.177.1.22
Oghumu, 2014, STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis, Eur. J. Immunol., 44, 450, 10.1002/eji.201343477
Stamm, 1999, STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis, Eur. J. Immunol., 29, 2524, 10.1002/(SICI)1521-4141(199908)29:08<2524::AID-IMMU2524>3.0.CO;2-H
Bullen, 2003, Persistence of lesions in suppressor of cytokine signaling-1-deficient mice infected with Leishmania major, J. Immunol., 170, 4267, 10.4049/jimmunol.170.8.4267
Alexander, 1999, SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine, Cell, 98, 597, 10.1016/S0092-8674(00)80047-1
Kinjyo, 2006, Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1, J. Exp. Med., 203, 1021, 10.1084/jem.20052333
Späth, 2008, Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/- mice, Exp. Parasitol., 120, 275, 10.1016/j.exppara.2008.07.003
Forget, 2001, Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis, Eur. J. Immunol., 31, 3185, 10.1002/1521-4141(200111)31:11<3185::AID-IMMU3185>3.0.CO;2-J
Wei, 1995, Altered immune responses in mice lacking inducible nitric oxide synthase, Nature, 375, 408, 10.1038/375408a0
Lohoff, 1997, Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo, Immunity, 6, 681, 10.1016/S1074-7613(00)80444-6
Rub, 2009, Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function, Nat. Immunol., 10, 273, 10.1038/ni.1705
S. Sen, K. Roy, S. Mukherjee, R. Mukhopadhyay, S. Roy, Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol., PLoS Pathog., 7(9), p. e1002229, Sep. 2011, doi: 10.1371/journal.ppat.1002229.
S. Majumder, et al., Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite, J. Infect. Dis., 205(10), pp. 1607–1616, May 2012, doi: 10.1093/infdis/jis229.
Dey, 2007, Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase, Infect. Immun., 75, 2136, 10.1128/IAI.01589-06
Parisien, 2002, Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction, J. Virol., 76, 4190, 10.1128/JVI.76.9.4190-4198.2002
Andrejeva, 2002, Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons, J. Virol., 76, 2159, 10.1128/jvi.76.5.2159-2167.2002
Parisien, 2001, The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2, Virology, 283, 230, 10.1006/viro.2001.0856
Gargan, 2018, HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction, EBioMedicine, 30, 203, 10.1016/j.ebiom.2018.03.006
Fanunza, 2021, Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2, Virulence, 12, 1580, 10.1080/21505594.2021.1935613
Forget, 2005, Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani, J. Biol. Chem., 280, 30542, 10.1074/jbc.M414126200
Matte, 2010, Leishmania donovani amastigotes impair gamma interferon-induced STAT1alpha nuclear translocation by blocking the interaction between STAT1alpha and importin-alpha5, Infect. Immun., 78, 3736, 10.1128/IAI.00046-10
Nandan, 1995, Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1, Infect. Immun., 63, 4495, 10.1128/iai.63.11.4495-4500.1995
Bhardwaj, 2005, Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana, Int. J. Parasitol., 35, 75, 10.1016/j.ijpara.2004.10.018
Endo, 1997, A new protein containing an SH2 domain that inhibits JAK kinases, Nature, 387, 921, 10.1038/43213
Naka, 1997, Structure and function of a new STAT-induced STAT inhibitor, Nature, 387, 924, 10.1038/43219
Starr, 1997, A family of cytokine-inducible inhibitors of signalling, Nature, 387, 917, 10.1038/43206
Hilton, 1998, Twenty proteins containing a C-terminal SOCS box form five structural classes, Proc. Natl. Acad. Sci. U. S. A., 95, 114, 10.1073/pnas.95.1.114
Chandrakar, 2020, Differential Induction of SOCS Isoforms by Leishmania donovani Impairs Macrophage-T Cell Cross-Talk and Host Defense, J. Immunol., 204, 596, 10.4049/jimmunol.1900412
Bertholet, 2003, Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation, Infect. Immun., 71, 2095, 10.1128/IAI.71.4.2095-2101.2003
Srivastav, 2014, Leishmania donovani Prevents Oxidative Burst-mediated Apoptosis of Host Macrophages through Selective Induction of Suppressors of Cytokine Signaling (SOCS) Proteins, J. Biol. Chem., 289, 1092, 10.1074/jbc.M113.496323
E.L. Telleria, et al., Leishmania infantum Infection Modulates the Jak-STAT Pathway in Lutzomyia longipalpis LL5 Embryonic Cells and Adult Females, and Affects Parasite Growth in the Sand Fly, Front. Tropical Dis., 2 (2021) 51, [Online]. Available: https://www.frontiersin.org/article/10.3389/fitd.2021.747820.
Dalpke, 2008, Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins, Immunobiology, 213, 225, 10.1016/j.imbio.2007.10.008
Forget, 2006, Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production, Infect. Immun., 74, 6272, 10.1128/IAI.00853-05
Forget, 2005, Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1, Eur. J. Immunol., 35, 1906, 10.1002/eji.200526037
Nandan, 2002, Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation, J. Biol. Chem., 277, 50190, 10.1074/jbc.M209210200
Abu-Dayyeh, 2008, Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif, PLoS Negl. Trop. Dis., 2, e305, 10.1371/journal.pntd.0000305
Blanchette, 1999, Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation, Eur. J. Immunol., 29, 3737, 10.1002/(SICI)1521-4141(199911)29:11<3737::AID-IMMU3737>3.0.CO;2-S
Gomez, 2009, Leishmania GP63 Alters Host Signaling Through Cleavage-Activated Protein Tyrosine Phosphatases, Sci. Signal., 2, 10.1126/scisignal.2000213
Olivier, 1998, Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression, J. Biol. Chem., 273, 13944, 10.1074/jbc.273.22.13944
Irie-Sasaki, 2001, CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling, Nature, 409, 349, 10.1038/35053086
Zhang, 2007, Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T, Proc. Natl. Acad. Sci. U. S. A., 104, 4060, 10.1073/pnas.0611665104
Ray, 2000, Inhibition of interferon-gamma signaling by Leishmania donovani, J. Infect. Dis., 181, 1121, 10.1086/315330
Dasgupta, 2003, Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells, Ann. Trop. Med. Parasitol., 97, 245, 10.1179/000349803235001714
Arora, 2003, PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4, J. Biol. Chem., 278, 21327, 10.1074/jbc.C300119200
Liu, 1998, Inhibition of Stat1-mediated gene activation by PIAS1, Proc. Natl. Acad. Sci. U. S. A., 95, 10626, 10.1073/pnas.95.18.10626
Chung, 1997, Specific inhibition of Stat3 signal transduction by PIAS3, Science, 278, 1803, 10.1126/science.278.5344.1803
Liu, 2001, A transcriptional corepressor of Stat1 with an essential LXXLL signature motif, Proc. Natl. Acad. Sci. U. S. A., 98, 3203, 10.1073/pnas.051489598
Saura, 1999, Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription, J. Mol. Biol., 289, 459, 10.1006/jmbi.1999.2752
De Stefano, 2006, The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages, J. Mol. Med. (Berl), 84, 65, 10.1007/s00109-005-0713-x
Kim, 1997, Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages, Biochem. Biophys. Res. Commun., 236, 655, 10.1006/bbrc.1997.7031
Kamijo, 1994, Requirement for transcription factor IRF-1 in NO synthase induction in macrophages, Science, 263, 1612, 10.1126/science.7510419
Weisz, 1994, Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation, J. Biol. Chem., 269, 8324, 10.1016/S0021-9258(17)37197-1
Calegari-Silva, 2009, NF-kappaB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection, Immunol. Lett., 127, 19, 10.1016/j.imlet.2009.08.009
Calegari‐Silva, 2018, Leishmania amazonensis downregulates macrophage iNOS expression via Histone Deacetylase 1 (HDAC1): a novel parasite evasion mechanism, Eur. J. Immunol., 48, 1188, 10.1002/eji.201747257
Cameron, 2004, Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway, J. Immunol., 173, 3297, 10.4049/jimmunol.173.5.3297
Gregory, 2008, A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression, Eur. J. Immunol., 38, 1071, 10.1002/eji.200737586
Sims, 1993, A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter, Mol. Cell. Biol., 13, 690
Neish, 1995, Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1, Mol. Cell. Biol., 15, 2558, 10.1128/MCB.15.5.2558
Garoufalis, 1994, Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors, J. Virol., 68, 4707, 10.1128/jvi.68.8.4707-4715.1994
Liu, 2004, Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein, J. Biol. Chem., 279, 55609, 10.1074/jbc.M406565200
Murphy, 1995, Regulation of interleukin 12 p40 expression through an NF-kappa B half-site, Mol. Cell. Biol., 15, 5258, 10.1128/MCB.15.10.5258
Plevy, 1997, Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins, Mol. Cell. Biol., 17, 4572, 10.1128/MCB.17.8.4572
Wang, 2000, An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages, J. Immunol., 165, 271, 10.4049/jimmunol.165.1.271
Jayakumar, 2008, Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells, Infect. Immun., 76, 2138, 10.1128/IAI.01252-07
Ghosh, 2002, Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase, Infect. Immun., 70, 6828, 10.1128/IAI.70.12.6828-6838.2002
Privé, 2000, Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages, Eur. J. Immunol., 30, 2235, 10.1002/1521-4141(2000)30:8<2235::AID-IMMU2235>3.0.CO;2-9
Samten, 2008, CREB, ATF, and AP-1 transcription factors regulate IFN-gamma secretion by human T cells in response to mycobacterial antigen, J. Immunol., 181, 2056, 10.4049/jimmunol.181.3.2056
H. Bowen, A. Kelly, T. Lee, P. Lavender, Control of cytokine gene transcription in Th1 and Th2 cells, Clin. Exp. allergy J. Br. Soc. Allergy Clin. Immunol., 38(9), pp. 1422–1431, Sep. 2008, doi: 10.1111/j.1365-2222.2008.03067.x.
Reiner, 1987, Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products, J. Immunol., 138, 1926, 10.4049/jimmunol.138.6.1926
Reiner, 1988, Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages, Proc. Natl. Acad. Sci. U. S. A., 85, 4330, 10.1073/pnas.85.12.4330
Lambertz, 2012, Secreted virulence factors and immune evasion in visceral leishmaniasis, J. Leukoc. Biol., 91, 887, 10.1189/jlb.0611326
Atayde, 2015, Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut, Cell Rep., 13, 957, 10.1016/j.celrep.2015.09.058
Silverman, 2010, Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells, J. Immunol., 185, 5011, 10.4049/jimmunol.1000541
I. Contreras, M.A. Gómez, O. Nguyen, M.T. Shio, R.W. McMaster, M. Olivier, Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63, PLoS Pathog., 6(10), p. e1001148, Oct. 2010, doi: 10.1371/journal.ppat.1001148.
Jaramillo, 2011, Leishmania Repression of Host Translation through mTOR Cleavage Is Required for Parasite Survival and Infection, Cell Host Microbe, 9, 331, 10.1016/j.chom.2011.03.008
Somanna, 2002, Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta, J. Biol. Chem., 277, 25305, 10.1074/jbc.M203034200
Gantt, 2003, Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages, J. Immunol., 170, 2613, 10.4049/jimmunol.170.5.2613
Buxbaum, 2003, Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity, J. Immunol., 171, 3711, 10.4049/jimmunol.171.7.3711
Abu-Dayyeh, 2010, Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions, Infect. Immun., 78, 2438, 10.1128/IAI.00812-09
Maretti-Mira, 2011, Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression, Clin. Exp. Immunol., 163, 207, 10.1111/j.1365-2249.2010.04285.x
Carvalho, 2005, Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients, Scand. J. Immunol., 61, 337, 10.1111/j.1365-3083.2005.01581.x
Resende, 2008, Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells, Vaccine, 26, 4585, 10.1016/j.vaccine.2008.05.091
Ghosh, 2001, Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections, Vaccine, 20, 59, 10.1016/S0264-410X(01)00322-X
Kavoosi, 2008, Leishmania major: effects of proteophosphoglycan on reactive oxygen species, IL-12, IFN-gamma and IL-10 production in healthy individuals, Exp. Parasitol., 120, 62, 10.1016/j.exppara.2008.04.022
Piani, 1999, Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function, Microbes Infect., 1, 589, 10.1016/S1286-4579(99)80058-6
T. Lieke, et al., Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation, Clin. Exp. Immunol., 153(2), pp. 221–230, Aug. 2008, doi: 10.1111/j.1365-2249.2008.03687.x.
Gomes, 2008, Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model, Proc. Natl. Acad. Sci. U. S. A., 105, 7845, 10.1073/pnas.0712153105
R. Silvestre, A. Cordeiro-Da-Silva, N. Santarém, B. Vergnes, D. Sereno, A. Ouaissi, SIR2-Deficient <em>Leishmania infantum</em> Induces a Defined IFN-γ/IL-10 Pattern That Correlates with Protection, J. Immunol., 179(5), pp. 3161 LP – 3170, Sep. 2007, doi: 10.4049/jimmunol.179.5.3161.
Uzonna, 2004, Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response, J. Immunol., 172, 3793, 10.4049/jimmunol.172.6.3793
Tewary, 2006, Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis, Vaccine, 24, 2409, 10.1016/j.vaccine.2005.11.058
P. Tewary, M. Jain, M.H. Sahani, S. Saxena, R. Madhubala, A Heterologous Prime-Boost Vaccination Regimen Using ORFF DNA and Recombinant ORFF Protein Confers Protective Immunity against Experimental Visceral Leishmaniasis, J. Infect. Dis., 191(12), pp. 2130–2137, Jan. 2005, [Online]. Available: http://www.jstor.org/stable/30077877.
M. Samant, et al., Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of <em>Leishmania donovani</em> Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis, J. Immunol., 183(1), pp. 470 LP – 479, Jul. 2009, doi: 10.4049/jimmunol.0900265.
Lakshmi, 2014, Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis, Vaccine, 32, 3816, 10.1016/j.vaccine.2014.04.088
Badaro, 1990, Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma, N. Engl. J. Med., 322, 16, 10.1056/NEJM199001043220104
Murray, 1985, Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma, J. Immunol., 134, 1619, 10.4049/jimmunol.134.3.1619
Murray, 1988, Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony, J. Infect. Dis., 157, 973, 10.1093/infdis/157.5.973
Sundar, 1994, Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma, J. Infect. Dis., 170, 659, 10.1093/infdis/170.3.659
Sundar, 1995, Immunochemotherapy for a Systemic Intracellular Infection: Accelerated Response Using Interferon-γ in Visceral Leishmaniasis, J. Infect. Dis., 171, 992, 10.1093/infdis/171.4.992
Squires, 1993, Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma, Am. J. Trop. Med. Hyg., 48, 666, 10.4269/ajtmh.1993.48.666
Harms, 1993, Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony, J. Interferon Res., 13, 39, 10.1089/jir.1993.13.39
Harms, 1989, Effects of intradermal gamma-interferon in cutaneous leishmaniasis, Lancet (London, England), 333, 1287, 10.1016/S0140-6736(89)92686-X
Murray, 1995, Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice, J. Infect. Dis., 171, 1309, 10.1093/infdis/171.5.1309
Wadhone, 2009, Miltefosine promotes IFN-gamma-dominated antileishmanial immune response, J. Immunol., 182, 7146, 10.4049/jimmunol.0803859
Sundar, 1995, Effect of treatment with interferon-gamma alone in visceral leishmaniasis, J. Infect. Dis., 172, 1627, 10.1093/infdis/172.6.1627
Ghosh, 2013, Immunomodulatory effects of antileishmanial drugs, J. Antimicrob. Chemother., 68, 2834, 10.1093/jac/dkt262